Article
Down syndrome and GATA1 mutations in transient abnormal myeloproliferative disorder: mutation classes correlate with progression to myeloid leukemia.
Blood - 25 Nov 2010
Kanezaki Rika, Toki Tsutomu, Terui Kiminori, Xu Gang, Wang Runan, Shimada Akira, Hama Asahito, Kanegane Hirokazu, Kawakami Kiyoshi, Endo Mikiya, Hasegawa Daisuke, Kogawa Kazuhiro, Adachi Souichi, Ikeda Yasuhiko, Iwamoto Shotaro, Taga Takashi, Kosaka Yoshiyuki, Kojima Seiji, Hayashi Yasuhide, Ito Etsuro
Abstract excerpt
Twenty percent to 30% of transient abnormal myelopoiesis (TAM) observed in newborns with Down syndrome (DS) develop myeloid leukemia of DS (ML-DS). Most cases of TAM carry somatic GATA1 mutations resulting in the exclusive expression of a truncated protein (GATA1s). However, there are no reports...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
